Cartesian Therapeutics(RNAC) - Prospectus(update)

TABLE OF CONTENTS As filed with the Securities and Exchange Commission on September 20, 2024 Registration No. 333-281204 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment No. 2 to FORM S-1 REGISTRATION STATEMENT UNDER Carsten Brunn, Ph.D. President and Chief Executive Officer Cartesian Therapeutics, Inc. 704 Quince Orchard Road Gaithersburg, MD 20878 (617) 923-1400 (Name, address, including zip code, and telephone number, including area code, of agent for service) Copies to: ...